Select Medical (NYSE:SEM) Rating Lowered to “Hold” at StockNews.com

Select Medical (NYSE:SEM) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday.

Several other equities analysts have also commented on the company. Royal Bank of Canada upped their target price on Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. Benchmark downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, November 25th. Finally, UBS Group decreased their target price on shares of Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a research report on Friday, January 3rd. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $39.50.

Select Medical Trading Up 1.8 %

NYSE:SEM traded up $0.35 on Wednesday, reaching $19.27. The stock had a trading volume of 767,805 shares, compared to its average volume of 922,353. Select Medical has a 12-month low of $18.02 and a 12-month high of $40.98. The company has a market cap of $2.49 billion, a price-to-earnings ratio of 9.00, a P/E/G ratio of 0.39 and a beta of 1.45. The firm’s fifty day moving average is $24.34 and its two-hundred day moving average is $31.32. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13.

Select Medical (NYSE:SEM) last announced its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.07. The business had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.74 billion. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The company’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.46 earnings per share. Equities analysts expect that Select Medical will post 1.97 EPS for the current fiscal year.

Insider Activity

In related news, VP Robert G. Breighner, Jr. sold 4,989 shares of the company’s stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total transaction of $99,530.55. Following the completion of the sale, the vice president now directly owns 30,356 shares of the company’s stock, valued at approximately $605,602.20. This represents a 14.12 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Marilyn B. Tavenner sold 32,000 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total value of $674,880.00. Following the completion of the transaction, the director now directly owns 22,000 shares in the company, valued at $463,980. This trade represents a 59.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 17.50% of the company’s stock.

Hedge Funds Weigh In On Select Medical

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Point72 Asset Management L.P. grew its holdings in Select Medical by 144.2% during the 3rd quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock valued at $71,825,000 after purchasing an additional 1,216,263 shares in the last quarter. Millennium Management LLC grew its stake in shares of Select Medical by 183.9% during the second quarter. Millennium Management LLC now owns 679,522 shares of the health services provider’s stock valued at $23,824,000 after acquiring an additional 440,140 shares in the last quarter. Hood River Capital Management LLC acquired a new position in shares of Select Medical in the second quarter worth about $14,819,000. Loomis Sayles & Co. L P purchased a new position in Select Medical in the third quarter valued at about $9,710,000. Finally, LMR Partners LLP acquired a new stake in Select Medical during the 3rd quarter valued at approximately $6,139,000. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.